EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924

Muriel Aline Spahn, Tom Van Loy, Sofie Celen, Michel Koole, Christophe M Deroose, Christopher Cawthorne, Wim Vanduffel, Dominique Schols, Guy Bormans, Frederik Cleeren iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-024-07025-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Muriel Aline Spahn und 9 weiteren Autor:innen. Beteiligte Einrichtung: Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Receptors, CXCR4, Fluorine Radioisotopes, Positron-Emission Tomography. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Tegen Kanker, Onderzoeksraad, KU Leuven, Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR4Fluorine RadioisotopesPositron-Emission TomographyAnimalsHumansMiceCell Line, TumorTissue DistributionIsotope LabelingPeptides, Cyclic

Stichwörter der Autor:innen

Al18FAl18F-NOTA-SCCXCR4PET

Substanzen

Receptors, CXCR4Fluorine RadioisotopesLY2510924Fluorine-18CXCR4 protein, humanPeptides, Cyclic

Autor:innen und Institutionen

  • Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, Molecular Structural and Translational Virology Research Group, Leuven, B-3000, Belgium.
  • Nuclear Medicine and Molecular Imaging, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Laboratory for Neuro- and Psychophysiology, KU Leuven Medical School, Leuven, Belgium.
  • Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium. frederik.cleeren@kuleuven.be.

ORCID-Profile: Frederik Cleeren

Förderung

  • Stichting Tegen Kanker
  • Onderzoeksraad, KU Leuven
  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Spahn, M. A., Loy, T. V., Celen, S., Koole, M., Deroose, C. M., Cawthorne, C., Vanduffel, W., Schols, D., Bormans, G., & Cleeren, F. (2025). Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-07025-w

Vancouver

Spahn MA, Loy TV, Celen S, Koole M, Deroose CM, Cawthorne C, et al. Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-024-07025-w

BibTeX
@article{Spahn2025,
  author = {Spahn, Muriel Aline and Loy, Tom Van and Celen, Sofie and Koole, Michel and Deroose, Christophe M and Cawthorne, Christopher and Vanduffel, Wim and Schols, Dominique and Bormans, Guy and Cleeren, Frederik},
  title = {Selective PET imaging of CXCR4 using the Al18F-labeled antagonist LY2510924},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-024-07025-w}
}
Kostenlos starten →